(Q39852808)

English

Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Kouji Izumi

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Atsushi Mizokami

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

You Qiang Li

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Kazutaka Narimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Kazuhiro Sugimoto

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Yoshifumi Kadono

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Yasuhide Kitagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hiroyuki Konaka

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Eitetsu Koh

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Evan T Keller

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Mikio Namiki

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

69

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1222-1234

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Prostate cancer. Primary hormonal treatment

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Chemotherapy for advanced hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Chemotherapy for patients with advanced prostate carcinoma: a new option for therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Prospective study of estramustine phosphate for hormone refractory prostate cancer patients following androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireview

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

The two faces of transforming growth factor beta in carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21(waf1) and p53.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Effects of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Live and let die: regulatory mechanisms in Fas-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20975

21 January 2018

Identifiers

10.1002/PROS.20975

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39852808&oldid=2091527668"